Grufity logo
Grufity logo
NMTC

NMTC - NeuroOne Medical Technologies Corp Stock Price, Fair Value and News

$3.26-0.06 (-1.81%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

82/100

NMTC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

82/100

NMTC

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NMTC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMTC Price Action

Last 7 days

-2.9%

Last 30 days

-20.2%

Last 90 days

-23.5%

Trailing 12 Months

-0.3%

NMTC RSI Chart

NMTC Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NMTC Valuation

Market Cap

28.6M

Price/Earnings (Trailing)

-4.12

Price/Sales (Trailing)

3.11

EV/EBITDA

-3.86

Price/Free Cashflow

-3.78

NMTC Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

NMTC Fundamentals

NMTC Revenue

Revenue (TTM)

9.2M

Rev. Growth (Yr)

34.29%

Rev. Growth (Qtr)

-35.63%

NMTC Earnings

Earnings (TTM)

-6.9M

Earnings Growth (Yr)

-4.91%

Earnings Growth (Qtr)

-65.66%

NMTC Profitability

Operating Margin

54.41%

EBT Margin

-75.50%

Return on Equity

-136.69%

Return on Assets

-91.69%

Free Cashflow Yield

-26.46%

NMTC Investor Care

Shares Dilution (1Y)

64.70%

Diluted EPS (TTM)

-0.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20269.2M---
20255.8M6.6M9.1M8.7M
20243.7M3.9M3.5M5.7M
2023681.6K1.3M2.0M2.8M
2022158.8K150.7K171.2K252.0K
2021120.6K149.4K178.1K140.4K
2020---91.8K
2013--34.2K63.0K
20112.2K3.3K4.3K5.4K
2010---1.2K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About NeuroOne Medical Technologies Corp

NMTC
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
 CEO
 WEBSITEn1mtc.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES15

NeuroOne Medical Technologies Corp Frequently Asked Questions

NMTC is the stock ticker symbol of NeuroOne Medical Technologies Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of NeuroOne Medical Technologies Corp is 28.6 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, NMTC's PE ratio (Price to Earnings) is -4.12 and Price to Sales (PS) ratio is 3.11. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NMTC PE ratio will change depending on the future growth rate expectations of investors.